help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Haeften, T. W.
Right arrow Articles by van der Veen, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Haeften, T. W.
Right arrow Articles by van der Veen, E. A.

Journal of Clinical Endocrinology & Metabolism, Vol 69, 1059-1064, Copyright © 1989 by Endocrine Society


ARTICLES

Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia

TW van Haeften, GA Voetberg, JE Gerich and EA van der Veen
Department of Endocrinology, Free University Hospital, Amsterdam, The Netherlands.

To test the hypothesis that glucose only affects the responsiveness (maximum velocity) of the beta-cell to arginine without changing the sensitivity (ED50) of the beta-cell to arginine, we investigated the influence of hyperglycemia on the responsiveness and sensitivity of arginine-induced insulin secretion in eight healthy male volunteers. Plasma C-peptide and insulin levels achieved during infusions of five doses of arginine (30 min) with and without a 60-min hyperglycemic clamp (17 mmol/L) were analyzed using a modified Michaelis-Menten equation. At euglycemia, the ED50 (half-maximally stimulating serum arginine concentration) was significantly less for first phase than for second phase plasma C-peptide secretion (0.7 +/- 0.1 vs. 2.7 +/- 0.4 mmol/L; P less than 0.002). Hyperglycemia significantly increased arginine-induced insulin secretion at all arginine infusion rates (P less than 0.01) without significantly altering the ED50 for either phase. We conclude 1) that the regulation of arginine-induced insulin secretion differs between both phases of insulin secretion, and 2) that a 1-h infusion with glucose significantly potentiates arginine-induced insulin secretion without influencing the difference in regulation of both phases of arginine-induced insulin secretion, supporting the validity of the use of arginine as a secretagogue in studies involving hyperglycemia.


This article has been cited by other articles:


Home page
J. Nutr.Home page
M. Ohtani, M. Sugita, and K. Maruyama
Amino Acid Mixture Improves Training Efficiency in Athletes
J. Nutr., February 1, 2006; 136(2): 538S - 543S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Brand-Miller, S. H. A. Holt, V. de Jong, and P. Petocz
Cocoa Powder Increases Postprandial Insulinemia in Lean Young Adults
J. Nutr., October 1, 2003; 133(10): 3149 - 3152.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Piatti, G. Fragasso, L. D. Monti, E. Setola, P. Lucotti, I. Fermo, R. Paroni, E. Galluccio, G. Pozza, S. Chierchia, et al.
Acute Intravenous l-Arginine Infusion Decreases Endothelin-1 Levels and Improves Endothelial Function in Patients With Angina Pectoris and Normal Coronary Arteriograms: Correlation With Asymmetric Dimethylarginine Levels
Circulation, January 28, 2003; 107(3): 429 - 436.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. C Gannon, J. A Nuttall, and F. Q Nuttall
Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal
Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1016 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Meyer, J. Sturis, M. Katschinski, R. Arnold, B. Goke, and M. M. Byrne
Acute hyperglycemia alters the ability of the normal beta -cell to sense and respond to glucose
Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E917 - E922.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society